ArticleJournal of health, population, and nutrition2026
Epidemiological characteristics and vaccination history analysis of pertussis in Quzhou from 2005 to 2024.
Article in Journal of health, population, and nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundDespite high vaccination coverage, pertussis is reemerging in China and increasingly affecting older children. This shift challenges current immunization strategies. To inform better prevention, we aimed to investigate pertussis epidemiology in Quzhou, with a focus on analyzing factors linked to the time between vaccination and illness onset among diagnosed cases.
methodsWe analyzed pertussis cases from the China Information System for Disease Control and Prevention (CISDCP) in Quzhou City (2005-2024) and linked them to vaccination records from the Zhejiang Immunization Program Smart Service Information System. The outcome variable was the time from the last vaccine dose to pertussis diagnosis.
resultsDuring 2005-2024, Quzhou reported 2,045 pertussis cases, with 93.25% concentrated in 2024. Case distribution shifted from 0 to 4 to ≥ 5 years (P < 0.001). Age‑specific incidence rose markedly in all groups in 2024 (all P < 0.001), with the highest rate observed among 5-9‑year‑olds (878.99/100,000). Among cases with known vaccination history, 83.86% had received at least one dose. Multivariable Cox regression showed that vaccination status and vaccine type were significantly associated with pertussis risk. Pertussis risk was 45% lower after the fourth dose than before it (P = 0.017). For vaccine type comparisons versus DTaP, the hazard ratio for pertussis was 0.11 for DTwP, 2.09 for DTaP-Hib, and 3.28 for DTaP-IPV/Hib (all P < 0.001).
conclusionsThe 2024 pertussis outbreak in Quzhou showed a marked age shift toward school-aged children, with the highest incidence in 5-9-year-olds. Our findings support adding a booster dose at 6 years of age and reconsidering multivalent DTaP-containing vaccines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.